<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Exp. Biol. Med.</journal-id>
<journal-title>Experimental Biology and Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Exp. Biol. Med.</abbrev-journal-title>
<issn pub-type="epub">1535-3699</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">10037</article-id>
<article-id pub-id-type="doi">10.3389/ebm.2024.10037</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Experimental Biology and Medicine</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Different narcotic gases and concentrations for immobilization of ostrich embryos for <italic>in-ovo</italic> imaging</article-title>
<alt-title alt-title-type="left-running-head">Perkas et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/ebm.2024.10037">10.3389/ebm.2024.10037</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Perkas</surname>
<given-names>O.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schmidt</surname>
<given-names>A.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kuehnel</surname>
<given-names>C.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Greiser</surname>
<given-names>J.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hermeyer</surname>
<given-names>H.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Klingner</surname>
<given-names>C.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Freesmeyer</surname>
<given-names>M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2538598/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Winkens</surname>
<given-names>T.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Clinic of Nuclear Medicine</institution>, <institution>Jena University Hospital</institution>, <addr-line>Jena</addr-line>, <addr-line>Thuringia</addr-line>, <country>Germany</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Translational Nuclear Medicine and Radiopharmacy</institution>, <institution>Clinic of Nuclear Medicine</institution>, <institution>Jena University Hospital</institution>, <addr-line>Jena</addr-line>, <addr-line>Thuringia</addr-line>, <country>Germany</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Neurology</institution>, <institution>Jena University Hospital</institution>, <addr-line>Jena</addr-line>, <country>Germany</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Biomagnetic Center</institution>, <institution>Jena University Hospital</institution>, <addr-line>Jena</addr-line>, <country>Germany</country>
</aff>
<author-notes>
<corresp id="c001">&#x2a;Correspondence: M. Freesmeyer, <email>martin.freesmeyer@med.uni-jena.de</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>05</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>249</volume>
<elocation-id>10037</elocation-id>
<history>
<date date-type="received">
<day>16</day>
<month>10</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>05</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Perkas, Schmidt, Kuehnel, Greiser, Hermeyer, Klingner, Freesmeyer and Winkens.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Perkas, Schmidt, Kuehnel, Greiser, Hermeyer, Klingner, Freesmeyer and Winkens</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>
<italic>In-ovo</italic> imaging using avian eggs has been described as a potential alternative to animal testing using rodents. However, imaging studies are hampered by embryonal motion producing artifacts. This study aims at systematically comparing isoflurane, desflurane and sevoflurane in three different concentrations in ostrich embryos. Biomagnetic signals of ostrich embryos were recorded analyzing cardiac action and motion. Ten groups comprising eight ostrich embryos each were investigated: Control, isoflurane (2%, 4%, and 6%), desflurane (6%, 12%, and 18%) and sevoflurane (3%, 5%, and 8%). Each ostrich egg was exposed to the same narcotic gas and concentration on development day (DD) 31 and 34. Narcotic gas exposure was upheld for 90&#xa0;min and embryos were monitored for additional 75&#xa0;min. Toxicity was evaluated by verifying embryo viability 24&#xa0;h after the experiments. Initial heart rate of mean 148 beats/min (DD 31) and 136 beats/min (DD 34) decreased over time by 44&#x2013;48 beats/minute. No significant differences were observed between groups. All narcotic gases led to distinct movement reduction after mean 8&#xa0;min. Embryos exposed to desflurane 6% showed residual movements. Isoflurane 6% and sevoflurane 8% produced motion-free time intervals of mean 70&#xa0;min after discontinuation of narcotic gas exposure. Only one embryo death occurred after narcotic gas exposure with desflurane 6%. This study shows that isoflurane, desflurane and sevoflurane are suitable for ostrich embryo immobilization, which is a prerequisite for motion-artifact free imaging. Application of isoflurane 6% and sevoflurane 8% is a) safe as no embryonal deaths occurred after exposure and b) effective as immobilization was observed for approx. 70&#xa0;min after the end of narcotic gas exposure. These results should be interpreted with caution regarding transferability to other avian species as differences in embryo size and incubation duration exist.</p>
</abstract>
<kwd-group>
<kwd>in-ovo imaging</kwd>
<kwd>ostrich eggs</kwd>
<kwd>animal model</kwd>
<kwd>biomagnetism</kwd>
<kwd>alternative animal testing</kwd>
<kwd>narcotic gases</kwd>
<kwd>magnet-ovography</kwd>
</kwd-group>
<contract-num rid="cn001">WI 5346/2-1 FR 2724/2-1</contract-num>
<contract-sponsor id="cn001">Deutsche Forschungsgemeinschaft<named-content content-type="fundref-id">10.13039/501100001659</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Impact statement</title>
<p>In-ovo imaging represents an adequate alternative for preclinical imaging sparing animal research using rodents. In order to avoid image artifacts caused by embryonal motion, use of isoflurane has been described previously. This work systematically investigated different narcotic gases and concentrations, showing successful immobilization for more than one hour after exposure using highest concentrations of isoflurane, desflurane and sevoflurane. This information is needed for planning and execution of in-ovo imaging experiments.</p>
</sec>
<sec id="s2">
<title>Introduction</title>
<p>
<italic>In-ovo</italic> imaging has been described as a potential alternative concept to animal testing using rats or mice [<xref ref-type="bibr" rid="B1">1</xref>&#x2013;<xref ref-type="bibr" rid="B4">4</xref>]. According to national and international legislation, research using eggs does not qualify as animal testing as long as all experiments are carried out before hatching [<xref ref-type="bibr" rid="B5">5</xref>&#x2013;<xref ref-type="bibr" rid="B8">8</xref>].</p>
<p>
<italic>In-ovo</italic> methods comprise experiments using chorio-allantois membrane (CAM), vaccine research and production, toxicity studies as well as cardiovascular research, just to name a few. The largest research area is covered by CAM assays, because this highly vascularized membrane enables basic research regarding cancer (tumor cell growth [<xref ref-type="bibr" rid="B9">9</xref>], xenografts [<xref ref-type="bibr" rid="B10">10</xref>], epithelial-mesenchymal transition [<xref ref-type="bibr" rid="B11">11</xref>], circulating tumor cells [<xref ref-type="bibr" rid="B12">12</xref>]), angiogenesis (pro- and antiangiogenetic drugs) [<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B14">14</xref>], wound healing, stem cells [<xref ref-type="bibr" rid="B15">15</xref>] and even serves as training platform for surgical procedures [<xref ref-type="bibr" rid="B16">16</xref>]. As these models have been shown to provide essential information about cell interactions, cancer and drug effects [<xref ref-type="bibr" rid="B17">17</xref>], they are suitable to answer important questions of basic research [<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>]. Regarding the role of <italic>in-ovo</italic> methods within the landscape of research in general, drug development is chosen as an example: It is commonly accepted that new drugs are tested on animals (i.e., rodents) before first application in humans in order to sort out drug candidates which are associated with toxicities. If there was a tool that allowed for an even earlier selection of promising drug candidates, this would reduce the number of animals needed.</p>
<p>With regard to preclinical imaging, <italic>in-ovo</italic> methods contribute to reduction of classic animal research using rodents as it can serve as a &#x201c;pre-selection tool&#x201d; in order to test and dismiss unfavorable experimental approaches (e.g., radiopharmaceutical substances for nuclear medicine imaging), so only promising experimental approaches are tested on rodents. Thus, <italic>in-ovo</italic> research complies with the principles of modern animal testing (3R) as established by Russel and Burch in 1959 [<xref ref-type="bibr" rid="B20">20</xref>].</p>
<p>Usually, chicken embryos are used for <italic>in-ovo</italic> imaging, however, this requires dedicated small animal imaging devices which represents a disadvantage regarding limited access [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B4">4</xref>]. A concept using substantially larger ostrich eggs and imaging devices commonly used in routine clinical examinations in humans (e.g., computed tomography, CT; magnet resonance imaging, MRI; and positron emission tomography, PET) has been published before [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B4">4</xref>].</p>
<p>Preclinical <italic>in-vivo</italic> imaging requires immobilization in order to produce artifact-free imaging [<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>]. In rodents, isoflurane anesthesia is an established method [<xref ref-type="bibr" rid="B23">23</xref>]. Previous publications report on the effect of isoflurane on chicken and ostrich embryos and have investigated feasibility and success of reduction of embryonal movements [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B22">22</xref>]. However, there are no studies that explore the effect of different narcotic gases and different concentrations.</p>
<p>Thus, this study aims at comparing isoflurane, desflurane and sevoflurane in three different concentrations. The frequency of movements and heart rate is assessed using biomagnetic signals. Furthermore, embryo survival after narcotic gas exposure is evaluated. Two different development stages of ostrich embryos are investigated, i.e., development day (DD) 31 and 34.</p>
</sec>
<sec sec-type="materials|methods" id="s3">
<title>Materials and methods</title>
<sec id="s3-1">
<title>Ostrich eggs</title>
<p>Ostrich eggs were obtained from a local ostrich farm 15&#xa0;km from the research facility between April and September. Artificial incubation was started 1&#x2013;4&#xa0;days after laying and was carried out using a multistage egg incubator (Sofie 3, Hemel, Verl, and Germany) with constant incubation properties at 36.5&#xb0;C and 25% air humidity as described elsewhere [<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B4">4</xref>]. The ostrich eggs used in this study were part of a larger research project comprising different experiments. During the time period, a total of 373 ostrich eggs were obtained. Non-fertilized eggs and eggs containing dead embryos were discarded. After 31&#xa0;days of incubation, 188 ostrich embryos were available for different experiments and of these, 85 ostrich embryos were randomly chosen to be investigated with different narcotic gases as described in this study. Initial egg weight was 1,398 &#xb1; 112&#xa0;g.</p>
<p>If artificially incubated, ostrich eggs usually hatch after 42&#xa0;days [<xref ref-type="bibr" rid="B24">24</xref>]. As it was a requirement to end all experiments before hatching, studies were performed on DD 31 and DD 34. This embryo study did not qualify as an animal research study according to the Federal German Animal Protection Act. Registration took place with the Office for Consumer Protection of the Thuringia State, registration number 22-2684-04-02-114/16. Thus, ethic committee&#x2019;s approval was waived.</p>
</sec>
<sec id="s3-2">
<title>Magnet-ovography (MOG)</title>
<p>Methodological aspects of detecting embryonal movement and cardiac action using standard magnetencephalograph (MEG, Neuromag, Elekta, Sweden) systems have been published before [<xref ref-type="bibr" rid="B1">1</xref>]. In short, MEG consists of multiple magnetometers, measuring magnetic flux and background noise [<xref ref-type="bibr" rid="B25">25</xref>]. Each magnetometer produces a graph (channel) showing the magnetic field change over time. Due to the negative influence of ferromagnetic objects close to the investigation site, all components have to be designed metal-free and thus, remote controls consisting of tubes and a chamber to hold the ostrich egg were used to apply different narcotic gases as described before [<xref ref-type="bibr" rid="B1">1</xref>].</p>
</sec>
<sec id="s3-3">
<title>Data acquisition and post-processing</title>
<p>Data acquisition followed chronological steps as outlined by Freesmeyer et al. comprising optimal egg positioning via visual verification of heart signals, followed by automated signal recording of each magnetometer channel [<xref ref-type="bibr" rid="B1">1</xref>]. Regarding data post-processing, cardiac signals were detected using a method which has been validated for human fetus observations described by Schmidt et al. in 2019, analyzing information about the signal amplitude (minimum-maximum), the overall signal strength, signal space angle and moving correlation coefficient [<xref ref-type="bibr" rid="B26">26</xref>]. Movement signals were evaluated by methods of Schmidt et al. (i.e., advanced automatic movement detection, using position changes of the heart signal vector over time) and Freesmeyer et al. (i.e., manual movement detection, using a threshold-based analysis of different signal frequency-bands of each magnetograph channel) [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B26">26</xref>]. In order to ensure comparability for both methods, a data set comprising two groups (control, isoflurane 6%) from Freesmeyer et al. was analyzed using both methods and agreement was determined using Bland-Altmann plots. The individual embryos studied by Freesmeyer et al. were the same as investigated in this analysis [<xref ref-type="bibr" rid="B1">1</xref>]. The other groups (isoflurane 4%, isoflurane 2%, desflurane, sevoflurane) were evaluated only using advanced automatic movement detection method due to time aspects. This schedule was deemed adequate in view of time efficiency as estimated duration for manual movement detection (Freesmeyer et al.) [<xref ref-type="bibr" rid="B1">1</xref>] is longer than advanced automatic movement detection (Schmidt et al.) [<xref ref-type="bibr" rid="B26">26</xref>].</p>
</sec>
<sec id="s3-4">
<title>Experimental design</title>
<p>Isoflurane (Piramal Healthcare, Mumbai, India), Desflurane (Suprane, Baxxter Inc., Illinois, United States) and Sevoflurane (Abbvie Inc., Illinois, United States) were used in three different concentrations according to the available range which was predefined by the respective vaporizers (Vapor 2000 Isofluran, Vapor 2000 Desfluran, Vapor 2000 Sevofluran each by Draeger, Luebeck, Germany). The lowest and highest possible concentration was investigated as well as a concentration in between. Ten groups were investigated: Control, isoflurane (2%, 4%, and 6%), desflurane (6%, 12%, and 18%) and sevoflurane (3%, 5%, and 8%). For each concentration, eight ostrich embryos were investigated on DD 31 and the same ostrich embryos were investigated on DD 34 again. Additionally, a control group comprising 8 ostrich eggs was evaluated without exposure to narcotic gases.</p>
<p>The experiments were conducted as described elsewhere [<xref ref-type="bibr" rid="B1">1</xref>]. In short, eggs were removed from the incubator and transferred to MEG facility. Surface temperature was measured using an infrared contactless thermometer (VOLTCRAFT IR 900-30S, Conrad Electronic, Hirschau, Germany) before and after MOG.</p>
<p>Eggs were placed into chamber connected to tubes which enabled in- and outflow of narcotic gases and ambient air. The chamber was set into the MEG device and signal quality was visually assessed. If a positive cardiac signal was visible, experiment started according to <xref ref-type="fig" rid="F1">Figure 1</xref>. After a resting phase of 15&#xa0;min, narcotic gas exposure was started and continuously monitored using a gas measurement module for anesthetic care (Scio Four Oxi, Draeger, Luebeck, Germany). In order to extract the respective narcotic gas from the vapor, ambient air (21% oxygen, 79% nitrogen) was used. The flow was set at 2&#xa0;L/min and adjusted as needed, always verifying the desired narcotic gas concentration via the gas measurement module. Narcotic gas exposure was upheld for 90&#xa0;min and then vaporizer was closed. Data acquisition was continued for additional 75&#xa0;min (follow-up phase) assessing possible re-appearance of embryonal movement. In total, data were continuously acquired for 180&#xa0;min. During resting phase and follow-up phase, ambient air was inflated into the chamber holding the ostrich egg, preventing accumulation of carbon dioxide and subsequent embryo suffocation. In the control group, ambient air was inflated into the chamber for 180&#xa0;min at a flow of 2&#xa0;L/min. After the experiment, eggs were transferred into incubator and viability of ostrich embryos was investigated approx. 24&#xa0;h later by 5&#xa0;min MOG measurement assessing for cardiac signals; thus, experiment toxicity was evaluated. After the last experiment (on DD 35; viability assessment), ostrich embryos were subjected to imaging studies on DD 37 after which they were sacrificed on DD 37 at the latest using sodium-pentobarbital. Necropsy comprising organ removal was performed aiming at verification of imaging studies.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Time schedule for narcotic gas exposure. Phase &#x201c;rest&#x201d; (15&#xa0;min) allows for reduction of embryonal arousal after egg transport to MEG-facility. This phase is followed by &#x201c;narcotic gas exposure&#x201d; (90&#xa0;min) and a &#x201c;follow-up phase&#x201d; (75&#xa0;min). During rest and follow-up phase, ambient air is inflated into the chamber holding the ostrich eggs. During &#x201c;narcotic gas exposure,&#x201d; respective narcotic gas is applied. In control group, during this phase ambient air is inflated. During 180&#xa0;min MOG, the ostrich egg is held by a container which is located at the head rest (a) of the MEG system. Narcotic gas inflow is provided by specific vapor (b) and narcotic gas outflow (c) is provided by exhaustion system. During the whole experiment, narcotic gas concentration was continuously measured using a gas measurement module (d) for anesthetic care (Scio Four Oxi, Draeger, Luebeck, Germany), ensuring adequate concentration of narcotic gas within the chamber holding the ostrich egg.</p>
</caption>
<graphic xlink:href="ebm-249-10037-g001.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>Statistics</title>
<p>Individual embryo heart rate was determined for each minute and median values within each group were calculated and compared. Graphs were designed to visually compare heart rate change over time. ANOVA method was used to determine differences between narcotic gases and concentrations regarding heart rate reduction over time.</p>
<p>Method agreement between manual movement detection and advanced automatic movement detection was evaluated by determination of levels of agreement described by Bland and Altmann [<xref ref-type="bibr" rid="B27">27</xref>].</p>
<p>Embryo movement was normalized for individual motion signal level during resting phase. Relative signal change was recorded for each minute and median values within each group were calculated. Groups were compared using graphs. Furthermore, a sigmoid fitting curve was calculated for each experiment and inflection points were determined as the time point of successful immobilization (&#x201c;sleep&#x201d;) and re-appearance of movement during follow-up phase (&#x201c;awake&#x201d;). Time points were compared for each group using Kruskal-Wallis-Test and <italic>p</italic> &#x3d; 0.05 as a level of significance.</p>
</sec>
</sec>
<sec sec-type="results" id="s4">
<title>Results</title>
<p>In total, 168 MOG comprising 85 ostrich eggs were carried out. Eight data sets from 5 ostrich eggs were excluded from analysis due to erroneous data recording, corrupt data files and inconsistent duration of narcotic gas exposure. One of 80 ostrich embryos died after exposure to desflurane (6%) on DD 34. In 79 ostrich embryos, positive heart signal was obtained approx. 24&#xa0;h after the last experiment, indicating survival. Necropsy revealed no abnormal findings attributable to narcotic gas exposure.</p>
<p>Between MOG start and end, mean temperature reduction was 6.1&#xb0;C and different narcotic gases did not differ significantly regarding temperature decrease.</p>
<p>Data reconstruction was successful using advanced automatic movement detection method. Comparison with manual movement detection method showed good agreement between control group and isoflurane 6% regarding motion analysis (<xref ref-type="fig" rid="F2">Figure 2</xref>). Duration of data reconstruction and evaluation ranged from 20&#xa0;min to 160&#xa0;min per data file comprising 180&#xa0;min.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Embryonal movement using advanced automated movement detection according to [<xref ref-type="bibr" rid="B26">26</xref>] in a data set derived from [<xref ref-type="bibr" rid="B1">1</xref>]. Left: Boxplot diagram showing level of activity during resting phase (0&#x2013;15&#xa0;min; grey) and isoflurane/ambient air (15&#x2013;105&#xa0;min; red) in two groups (isoflurane 6% and control) on DD 34. Right: Four Bland-Altmann plots showing adequate agreement of advanced automated movement detection and manual movement detection. The four plots refer to the four boxes in the boxplot diagram. The Bland-Altmann plots compare each value between advanced automated movement detection and manual movement detection. The dots indicate the difference between both methods (y-axis) over absolute value (embryonal movement; x-axis) and the solid line represents the mean value of all dots. Dashed lines indicate 2x standard deviation of all differences. All values are in the range of 2x standard deviation, indicating no significant underestimation or overestimation.</p>
</caption>
<graphic xlink:href="ebm-249-10037-g002.tif"/>
</fig>
<sec id="s4-1">
<title>Heart rate</title>
<p>Heart rate change over time is shown in <xref ref-type="fig" rid="F3">Figure 3</xref> for all embryos on DD 31 and DD 34, respectively. On DD 34, ostrich embryos showed significant lower heart rate (106.9 &#xb1; 14.6/min) than ostrich embryos on DD 31 (140.9 &#xb1; 15.8/min) during the first 5&#xa0;min after exposure to narcotic gases (<italic>p</italic> &#x3c; 0.001).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Boxplot diagram of heart rate during different time intervals of all 80 ostrich embryos investigated on DD 31 and 34. Significant differences between DD 31 and DD 34 occur within the first 5&#xa0;min after initiation of narcotic gas exposure, in the middle of narcotic gas exposure and at the end of follow-up. Aggregated data of all groups including control group was deemed appropriate in view of <xref ref-type="fig" rid="F4">Figures 4</xref>, <xref ref-type="fig" rid="F5">5</xref>, excluding significant differences between control group and narcotic gases. &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001.</p>
</caption>
<graphic xlink:href="ebm-249-10037-g003.tif"/>
</fig>
<p>
<xref ref-type="fig" rid="F4">Figure 4</xref> visualizes effects of isoflurane, desflurane and sevoflurane over time. Mean heart rate reduction between time intervals 0&#x2013;15&#xa0;min and 151&#x2013;180&#xa0;min was 43.8/min on DD 31 and 47.7/min on DD 34, respectively; there was no significant difference between control group and narcotic gases and different concentrations (<xref ref-type="fig" rid="F5">Figure 5</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Mean heart rate over time for each narcotic gas and concentration (green: isoflurane, blue: desflurane; orange: sevoflurane). Top row: DD 31; bottom row: DD 34. In each graph, control group is depicted in grey. Dashed lines represent start and end of narcotic gas exposure. In each group, eight ostrich embryos on DD 31 and 34 were investigated, respectively.</p>
</caption>
<graphic xlink:href="ebm-249-10037-g004.tif"/>
</fig>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Boxplot diagram of mean heart rate reduction (difference) between 0&#x2013;15&#xa0;min and 151&#x2013;180&#xa0;min for each narcotic gas and concentration. Considering DD 31 and DD 34 separately, comparison between control group and each narcotic gas and concentration revealed no significant differences.</p>
</caption>
<graphic xlink:href="ebm-249-10037-g005.tif"/>
</fig>
</sec>
<sec id="s4-2">
<title>Embryonal movement</title>
<p>Embryonal movement over time is shown in <xref ref-type="fig" rid="F6">Figure 6</xref>, aiming at visualization of immobilization effect. Control groups on DD 31 and DD 34 (grey lines) differ slightly without significant differences while less embryonal movement is detectable when using highest concentrations for isoflurane, desflurane and sevoflurane, respectively. <xref ref-type="fig" rid="F7">Figure 7</xref> visualizes effectiveness of immobilization using time points &#x201c;sleep&#x201d; and &#x201c;awake&#x201d; in minutes after starting and ending narcotic gas inflow, respectively. On DD 34, highest concentration of isoflurane, desflurane and sevoflurane lead to a significantly different median time point &#x201c;sleep&#x201d; of 7.5 &#xb1; 2.1&#xa0;min, 3.0 &#xb1; 1.5&#xa0;min and 3.5 &#xb1; 1.4&#xa0;min, respectively (<italic>p</italic> &#x3d; 0.0169) and a significantly different time point &#x201c;awake&#x201d; of 75.0 &#xb1; 5.7&#xa0;min, 46.0 &#xb1; 9.6&#xa0;min, and 71.0 &#xb1; 21.4&#xa0;min, respectively (<italic>p</italic> &#x3d; 0.0252). There is no significant difference between low, medium and high concentration within each narcotic gas group. On DD 31 and DD 34, sevoflurane produces a significantly shorter median time for the ostrich embryo to &#x201c;sleep&#x201d; (DD 31: 4.0 &#xb1; 1.7&#xa0;min; DD 34: 4.0 &#xb1; 3.5&#xa0;min) than isoflurane (DD 31: 7.0 &#xb1; 4.7&#xa0;min; DD 34: 8.0 &#xb1; 5.5&#xa0;min) and desflurane (DD 31: 6.0 &#xb1; 5.3&#xa0;min; DD 34: 6.0 &#xb1; 4.5&#xa0;min) (DD 31: <italic>p</italic> &#x3d; 0.0143; DD 34: <italic>p</italic> &#x3d; 0.0015). Over all narcotic gas groups and concentrations, ostrich embryos awake earlier on DD 31 (24.0 &#xb1; 22.1&#xa0;min) than on DD 34 (37.0 &#xb1; 22.6&#xa0;min) (<italic>p</italic> &#x3d; 0.0016).</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Mean embryonal movement over time for each narcotic gas and concentration (green: isoflurane, blue: desflurane; orange: sevoflurane). Top row: DD 31; bottom row: DD 34. In both rows, results of control groups are depicted in grey. Dashed lines represent start and end of narcotic gas exposure. Note the light blue graph on DD 31 and DD 34 (desflurane 6%) during narcotic gas exposure (15&#x2013;105&#xa0;min) which indicates residual movement whereas the other graphs (desflurane 12%, 18%; sevoflurane, isoflurane) show almost constant 0 values. This figure mainly focuses on visualization of group differences. For quantification of effectiveness of immobilization, see <xref ref-type="fig" rid="F7">Figure 7</xref>.</p>
</caption>
<graphic xlink:href="ebm-249-10037-g006.tif"/>
</fig>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Boxplot diagram of duration between start of narcotic gas exposure and reduction of movements (&#x201c;time point sleep&#x201d;; left diagrams) as well as duration between end of narcotic gas exposure and re-appearance of movements (&#x201c;time point awake&#x201d;; right diagrams) for ostrich embryos on DD 31 (top row) and DD 34 (bottom row). In order to compare concentration levels of narcotic gases, categories &#x201c;low,&#x201d; &#x201c;medium&#x201d; and &#x201c;high&#x201d; were used as provided by dedicated vaporizers. Note the shorter time until re-appearance of movements for desflurane [as compared to sevoflurane and isoflurane (highest concentrations)] on DD 34. &#x2a;<italic>p</italic> &#x3c; 0.05; &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01; &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001.</p>
</caption>
<graphic xlink:href="ebm-249-10037-g007.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s5">
<title>Discussion</title>
<p>Isoflurane, desflurane and sevoflurane were compared in three different concentrations regarding effect on ostrich embryo motion and heart rate.</p>
<sec id="s5-1">
<title>Method agreement</title>
<p>Both methods of movement detection, i.e., manual movement detection and advanced automatic movement detection showed a good agreement in a dataset (comprising control group and isoflurane 6% on DD 34) retrieved from [<xref ref-type="bibr" rid="B1">1</xref>], thus confirming appropriateness of automatic movement detection. As data reconstruction and evaluation was shorter for the automatic approach, this method was chosen for comparison of different narcotic gases and concentrations. Initially, the algorithm for automatic movement detection was designed for human fetuses of 34&#x2013;38&#xa0;weeks of gestational age [<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B28">28</xref>]. Human fetuses of that age weigh approx. 2400&#x2013;3400&#xa0;g [<xref ref-type="bibr" rid="B29">29</xref>], which is about ten times heavier than an ostrich embryo of approx. 350&#xa0;g on DD 34 and 220&#xa0;g on DD 31, respectively. However, less weight did not hamper MOG signal detection as the algorithm produced adequate results. This study revealed that data reconstruction and evaluation using the automatic approach (as short as 20&#xa0;min) was faster than manual movement detection which required at least 45&#xa0;min for a 90&#xa0;min-data file, as reported by Freesmeyer et al. [<xref ref-type="bibr" rid="B1">1</xref>].</p>
</sec>
<sec id="s5-2">
<title>Embryonal movement</title>
<p>The three narcotic gases show comparable results regarding efficacy of movement reduction during exposure. After less than 8&#xa0;min, ostrich embryos show a distinct cessation of movements and sevoflurane was most effective with this regard. Only one group (desflurane 6%) which represents the lowest concentration for this gas, showed residual movements during narcotic gas exposure (15&#x2013;105&#xa0;min) (<xref ref-type="fig" rid="F6">Figure 6</xref>). After discontinuation of narcotic gas exposure, ostrich embryos having been exposed to desflurane showed a significantly shorter time until reappearance of first movements than isoflurane and sevoflurane, indicating inferior immobilization effects of desflurane (<xref ref-type="fig" rid="F7">Figure 7</xref>). As expected, highest concentrations of each narcotic gas produced a longer immobilization than lowest concentration (<xref ref-type="fig" rid="F6">Figure 6</xref>), however, this result was not significant (<xref ref-type="fig" rid="F7">Figure 7</xref>). This finding is in line with results showing more depression of motor evoked potentials in rats being exposed to higher concentrations of isoflurane [<xref ref-type="bibr" rid="B30">30</xref>].</p>
<p>Regarding ostrich eggs, only one study has addressed the effect of immobilization using narcotic gases, i.e., isoflurane [<xref ref-type="bibr" rid="B1">1</xref>]; however not investigating different concentrations. Heidrich et al. have successfully used isoflurane in chicken embryos in order to enable artifact free imaging, but also did not investigate different concentrations of isoflurane [<xref ref-type="bibr" rid="B22">22</xref>]. Dose-dependent effects of desflurane and other narcotic gases are well-known [<xref ref-type="bibr" rid="B31">31</xref>] and adjustment of concentrations represent common clinical practice in anesthetic management of patients. Chambers holding ostrich eggs and preventing leakage of narcotic gases might produce image artifacts [<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B32">32</xref>], thus, the setup described in this study aimed at narcotic gas exposure before imaging procedure. In this context, it is very important to consider the time from the end of narcotic gas exposure and reappearance of movements. This time span is required to establish a vessel access in order to intravenously administer substances, e.g., radiopharmaceuticals for <italic>in-vivo</italic> imaging. On DD 34, desflurane in its highest concentration (18%) led to an earlier reappearance of movements in ostrich embryos than isoflurane and sevoflurane, respectively (<xref ref-type="fig" rid="F7">Figure 7</xref>). Thus, desflurane is less suitable to suppress embryonal movement, whereas isoflurane and sevoflurane allow for artifact-free imaging after mean 70&#xa0;min after the end of narcotic gas exposure.</p>
</sec>
<sec id="s5-3">
<title>Heart rate</title>
<p>Heart rate reduction over time was present in all individuals including control group which indicates factors independent from narcotic gases as the underlying reason. Continuous cooling of ostrich eggs during experiments is considered the main factor as a mean reduction of 6.1&#xb0;C was observed in this study. Similar effects were reported previously using the same methodological approach [<xref ref-type="bibr" rid="B1">1</xref>]. MOG requires a complex MEG-system shielding of the entire room to suppress external magnetic field changes interfering with detection of magnetic flux. Also, MEG-system relies on constant room temperature of 25&#xb0;C which makes cooling of the ostrich eggs inevitable. Due to close proximity of ostrich eggs and magnetometers, thermal support with heating pads was not possible as it would have also increased the temperature of magnetometers, thus hampering MOG. Interpreting the heart rate reduction over time for each narcotic gas and concentration separately indicates a slightly pronounced decrease after initiation of narcotic gas exposure (16&#x2013;20&#xa0;min) and continuous (linear) reduction during narcotic gas exposure and follow-up; however, this difference is not significant (<xref ref-type="fig" rid="F4">Figures 4</xref>, <xref ref-type="fig" rid="F5">5</xref>). Concluding, heart rate reduction is present in all ostrich embryos and occurs independently from narcotic gas exposure.</p>
<p>This study revealed low toxicity of repeated narcotic gas exposure as all individual survived experiments on DD 31 and 79/80 embryos survived experiments on DD 34. The assessment of viability 24&#xa0;h after the last experiment was deemed appropriate to verify lethality. Regarding toxicity, da Rosa et al. investigated effects of isoflurane and sevoflurane in low concentrations on fertility of mice [<xref ref-type="bibr" rid="B33">33</xref>] and Liu et al. reported on long-term neurotoxicity of isoflurane and sevoflurane in neonatal mice [<xref ref-type="bibr" rid="B34">34</xref>]; however, both studies consider long-term effects and not short-term survival as in this study. Ostrich embryos were sacrificed on DD 37 at the latest, i.e., three days after last exposure to narcotic gases. Therefore, long-term effects of narcotic gases on ostrich embryos cannot be assessed using the current experimental setup.</p>
<p>All ostrich embryos underwent narcotic gas exposure on DD 31 and DD 34. This approach was chosen in order to show feasibility and safety of narcotic gases even in repeated experiments. As it is the goal to enable artifact-free imaging of ostrich embryos, repeated experiments in the same animal is desirable in order to reduce the number of embryos used in an experiment. Few differences were present between these two development stages which are predominantly characterized by embryo growth; organogenesis is complete at this late time point [<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B35">35</xref>]. Namely, significant lower heart rate was observed in embryos on DD 34 in the first 5&#xa0;minutes after initiation of narcotic gas exposure as well as at the end of follow-up-phase (<xref ref-type="fig" rid="F3">Figure 3</xref>) and ostrich embryos on DD 31 show a faster re-appearance of movements after discontinuation of narcotic gas exposure than embryos on DD 34. These are unexpected results as the applied narcotic gas divided by embryo weight is much higher in embryos on DD 31 (data not shown) and should lead to a stronger effect than in further developed embryos. It is well known that in general, heart rate is higher in smaller and younger individuals; however, this does not explain the differences in reaction to narcotic gas exposure. One possible explanation is the repetition of narcotic gas exposure.</p>
<p>All embryos investigated on DD 34 had been investigated with the same narcotic gas in the same concentration 3&#xa0;days before. This might indicate a cumulative effect of narcotic gases; however, this assumption cannot be proven with the current setup and would require experiments comprising a control group of embryos on DD 34 without prior narcotic gas exposure.</p>
</sec>
<sec id="s5-4">
<title>Limitations</title>
<p>This study addresses important questions regarding the effect of narcotic gases; however, the following limitations have to be considered: The experiments investigated only two time points during development, i.e., DD 31 and 34. Especially considering unexpected results between both time points regarding heart rate, experiments on further time points, i.e., DD 37 and 28 are important to transfer feasibility of immobilization via narcotic gases.</p>
<p>The system setup of MOG is rather elaborate due to extensive shielding and necessary metal-free environment. More compact and mobile systems would be desirable in order to enable simultaneous detection of cardiac action/movements and acquisition of images (CT, MRI, and PET).</p>
<p>The concept of using ostrich embryos as an alternative for animal testing is rather new and not (yet) widely distributed and results cannot be transferred without limitations to more commonly used chicken eggs or even mammals. Furthermore, it is unknown whether narcotic gases might influence experiments (e.g., normal biodistribution of radiopharmaceuticals) in ostrich embryos.</p>
</sec>
<sec id="s5-5">
<title>Conclusion</title>
<p>This study investigated desflurane, isoflurane and sevoflurane in three different concentrations for immobilization of ostrich embryos in order to enable motion artifact-free imaging. Minor methodological changes regarding automation of data reconstruction were successfully applied. Isoflurane and sevoflurane in their respective highest concentration (as permitted by the dedicated vaporizers), i.e. 6 % and 8%, respectively, were most suitable for immobilization which lasted for approx. 70&#xa0;min after discontinuation of narcotic gas exposure. All three narcotic gases are considered safe as only one of 80 embryos (160 experiments) died after narcotic gas (i.e., desflurane) exposure and heart rate did not change significantly when compared to a control group.</p>
</sec>
</sec>
</body>
<back>
<sec id="s6">
<title>Author contributions</title>
<p>Conceptualization: MF and TW, methodology: AS, JG, CrK, and TW; formal analysis and investigation: AS, HH, and OP, resources and supervision: MF, TW, and CaK, writing&#x2013;original draft preparation: OP and TW, Writing&#x2013;review and editing: all authors, Project administration and Funding Acquisition: MF and TW. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec sec-type="data-availability" id="s7">
<title>Data availability statement</title>
<p>The raw data supporting the conclusion of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s8">
<title>Ethics statement</title>
<p>The requirement of ethical approval was waived by Office for Consumer Protection of the Thuringia State, registration number 22-2684-04-02-114/16 for the studies involving animals because this embryo study did not qualify as an animal research study according to the Federal German Animal Protection Act. The studies were conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec sec-type="funding-information" id="s9">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. MF and TW disclose receipt of the following financial support for the research, authorship, and publication of this article: This work was supported by the Deutsche Forschungsgemeinschaft (grant number FR 2724/2-1) and (grant number WI 5346/2-1).</p>
</sec>
<ack>
<p>Anna Christl, Wiebke Neuschulz, Michelle Wallrodt, Oliver Hinze, Ferdinand Ndum and Veronika Porwoll are acknowledged for assistance in data analysis. We thank Prof. Dr. Otto W. Witte for granting access to Neuromag system and Dr. Ralph Huonker for technical support with Neuromag system. PD Dr. Thomas Bartels and Dr. Sabine Bischoff are acknowledged for veterinary support.</p>
</ack>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Freesmeyer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hermeyer</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kuehnel</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Perkas</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Greiser</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Witte</surname>
<given-names>OW</given-names>
</name>
<etal/>
</person-group> <article-title>In-ovo imaging using ostrich eggs: biomagnetism for detection of cardiac signals and embryonal motion</article-title>. <source>Exp Biol Med (Maywood)</source> (<year>2022</year>) <volume>247</volume>:<fpage>996</fpage>&#x2013;<lpage>1004</lpage>. <pub-id pub-id-type="doi">10.1177/15353702221082046</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Winkens</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Christl</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kuehnel</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ndum</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Seifert</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Greiser</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group> <article-title>In-ovo imaging using ostrich eggs-Evaluation of physiological embryonal development on computed tomography</article-title>. <source>Acta Zoologica</source> (<year>2021</year>) <volume>103</volume>:<fpage>492</fpage>&#x2013;<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1111/azo.12400</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Winkens</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kuehnel</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Freesmeyer</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>In-ovo imaging using ostrich eggs - replacement of animal studies?</article-title> <source>J Nucl Med</source> (<year>2020</year>) <volume>61</volume>:<fpage>1122</fpage>.</citation>
</ref>
<ref id="B4">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Freesmeyer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kuehnel</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Opfermann</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Niksch</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wiegand</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Stolz</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group> <article-title>The use of ostrich eggs for in ovo research: making preclinical imaging research affordable and available</article-title>. <source>J Nucl Med</source> (<year>2018</year>) <volume>59</volume>:<fpage>1901</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.2967/jnumed.118.210310</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Leary</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Anthony</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Cartner</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Grandin</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Greenacre</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gwaltney-Brant</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group> <source>AVMA guidelines for the euthanasia of animals: 2020 edition</source>. <publisher-loc>Schaumburg, IL, USA</publisher-loc>: <publisher-name>American Veterinary Medical Association</publisher-name> (<year>2020</year>).</citation>
</ref>
<ref id="B6">
<label>6.</label>
<citation citation-type="book">
<collab>Europ&#xe4;isches Parlament und Rat.</collab> <source>Richtlinie 2010/63/EU zum Schutz der f&#xfc;r wissenschaftliche Zwecke verwendeten Tiere</source> (<year>2010</year>).</citation>
</ref>
<ref id="B7">
<label>7.</label>
<citation citation-type="book">
<collab>Bundesministerium der Justiz und f&#xfc;r Verbraucherschutz.</collab> <source>Tierschutzgesetz</source> (<year>2016</year>).</citation>
</ref>
<ref id="B8">
<label>8.</label>
<citation citation-type="book">
<collab>United States Department of Agriculture.</collab> <source>Animal welfare act and animal welfare regulations</source> (<year>2013</year>).</citation>
</ref>
<ref id="B9">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schneider-Stock</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Fl&#xfc;gen</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>Editorial for special issue: the chorioallantoic membrane (CAM) model-traditional and state-of-the art applications: the 1st international CAM conference</article-title>. <source>Cancers (Basel)</source> (<year>2023</year>) <volume>15</volume>:<fpage>772</fpage>. <pub-id pub-id-type="doi">10.3390/cancers15030772</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tai</surname>
<given-names>YK</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>KKW</given-names>
</name>
<name>
<surname>Fong</surname>
<given-names>CHH</given-names>
</name>
<name>
<surname>Ramanan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yap</surname>
<given-names>JLY</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>JN</given-names>
</name>
<etal/>
</person-group> <article-title>Modulated TRPC1 expression predicts sensitivity of breast cancer to doxorubicin and magnetic field therapy: segue towards a precision medicine approach</article-title>. <source>Front Oncol</source> (<year>2021</year>) <volume>11</volume>:<fpage>783803</fpage>. <pub-id pub-id-type="doi">10.3389/fonc.2021.783803</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheng</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>Defining epithelial-mesenchymal transitions in animal development</article-title>. <source>Development</source> (<year>2021</year>) <volume>148</volume>:<fpage>dev198036</fpage>. <pub-id pub-id-type="doi">10.1242/dev.198036</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fluegen</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Avivar-Valderas</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Padgen</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Nobre</surname>
<given-names>AR</given-names>
</name>
<etal/>
</person-group> <article-title>Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments</article-title>. <source>Nat Cell Biol</source> (<year>2017</year>) <volume>19</volume>:<fpage>120</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1038/ncb3465</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swaminathan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Balaguru</surname>
<given-names>UM</given-names>
</name>
<name>
<surname>Manjunathan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bhuvaneswari</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kasiviswanathan</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sirishakalyani</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group> <article-title>Live imaging and analysis of vasoactive properties of drugs using an in-ovo chicken embryo model: replacing and reducing animal testing</article-title>. <source>Microsc Microanal</source> (<year>2019</year>) <volume>25</volume>:<fpage>961</fpage>&#x2013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1017/s1431927619000588</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farzaneh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Attari</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Khoshnam</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Mozdziak</surname>
<given-names>PE</given-names>
</name>
</person-group>. <article-title>The method of chicken whole embryo culture using the eggshell windowing, surrogate eggshell and ex ovo culture system</article-title>. <source>Br Poult Sci</source> (<year>2018</year>) <volume>59</volume>:<fpage>240</fpage>&#x2013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1080/00071668.2017.1413234</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinto</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Ribeiro</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Paredes</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>The chick CAM as an <italic>in vivo</italic> system to study stem cell activity</article-title>. <source>Methods Mol Biol</source> (<year>2023</year>) <volume>2572</volume>:<fpage>155</fpage>&#x2013;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-0716-2703-7_12</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leng</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Bilbao</surname>
<given-names>KV</given-names>
</name>
<name>
<surname>Palanker</surname>
<given-names>DV</given-names>
</name>
<name>
<surname>Huie</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Blumenkranz</surname>
<given-names>MS</given-names>
</name>
</person-group>. <article-title>The chick chorioallantoic membrane as a model tissue for surgical retinal research and simulation</article-title>. <source>Retina</source> (<year>2004</year>) <volume>24</volume>:<fpage>427</fpage>&#x2013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1097/00006982-200406000-00014</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barnett</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Herrmann</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gash</surname>
<given-names>EN</given-names>
</name>
<name>
<surname>Poptani</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sacco</surname>
<given-names>JJ</given-names>
</name>
<etal/>
</person-group> <article-title>The chick embryo xenograft model for malignant pleural mesothelioma: a cost and time efficient 3Rs model for drug target evaluation</article-title>. <source>Cancers (Basel)</source> (<year>2022</year>) <volume>14</volume>:<fpage>5836</fpage>. <pub-id pub-id-type="doi">10.3390/cancers14235836</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rashidi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sottile</surname>
<given-names>V</given-names>
</name>
</person-group>. <article-title>The chick embryo: hatching a model for contemporary biomedical research</article-title>. <source>Bioessays</source> (<year>2009</year>) <volume>31</volume>:<fpage>459</fpage>&#x2013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1002/bies.200800168</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ribatti</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>The chick embryo chorioallantoic membrane (CAM). A multifaceted experimental model</article-title>. <source>Mech Dev</source> (<year>2016</year>) <volume>141</volume>:<fpage>70</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.mod.2016.05.003</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Russell</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Burch</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>Principles of humane experimental-technique - russell,Wms, Burch</article-title>. <source>Rl Roy Soc Health J</source> (<year>1959</year>) <volume>79</volume>:<fpage>700</fpage>.</citation>
</ref>
<ref id="B21">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gebhardt</surname>
<given-names>P</given-names>
</name>
<name>
<surname>W&#xfc;rbach</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Heidrich</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Heinrich</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Walther</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Opfermann</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group> <article-title>Dynamic behaviour of selected PET tracers in embryonated chicken eggs</article-title>. <source>Revista Espa&#xf1;ola de Medicina Nucl e Imagen Mol</source> (<year>2013</year>) <volume>32</volume>:<fpage>371</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.remnie.2013.09.013</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heidrich</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wurbach</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Opfermann</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Saluz</surname>
<given-names>HP</given-names>
</name>
</person-group>. <article-title>Motion-artifact-free <italic>in vivo</italic> imaging utilizing narcotized avian embryos in ovo</article-title>. <source>Mol Imaging Biol</source> (<year>2011</year>) <volume>13</volume>:<fpage>208</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1007/s11307-010-0355-4</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neag</surname>
<given-names>M-A</given-names>
</name>
<name>
<surname>Mitre</surname>
<given-names>A-O</given-names>
</name>
<name>
<surname>Catinean</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mitre</surname>
<given-names>C-I</given-names>
</name>
</person-group>. <article-title>An overview on the mechanisms of neuroprotection and neurotoxicity of isoflurane and sevoflurane in experimental studies</article-title>. <source>Brain Res Bull</source> (<year>2020</year>) <volume>165</volume>:<fpage>281</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresbull.2020.10.011</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gefen</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ar</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Morphological description of the developing ostrich embryo: a tool for embryonic age estimation</article-title>. <source>Isr J Zoolog</source> (<year>2001</year>) <volume>47</volume>:<fpage>87</fpage>&#x2013;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1092/h2t8-1h2u-81h1-p5xy</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>H&#xe4;m&#xe4;l&#xe4;inen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hari</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ilmoniemi</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Knuutila</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lounasmaa</surname>
<given-names>OV</given-names>
</name>
</person-group>. <article-title>Magnetoencephalography theory, instrumentation, and applications to noninvasive studies of the working human brain</article-title>. <source>Rev Mod Phys</source> (<year>1993</year>) <volume>65</volume>:<fpage>413</fpage>&#x2013;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1103/revmodphys.65.413</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmidt</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Witte</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Swiderski</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Z&#xf6;llkau</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Hoyer</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>Advanced automatic detection of fetal body movements from multichannel magnetocardiographic signals</article-title>. <source>Physiol Meas</source> (<year>2019</year>) <volume>40</volume>:<fpage>085005</fpage>. <pub-id pub-id-type="doi">10.1088/1361-6579/ab3c96</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bland</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Altman</surname>
<given-names>DG</given-names>
</name>
</person-group>. <article-title>Statistical methods for assessing agreement between two methods of clinical measurement</article-title>. <source>Lancet</source> (<year>1986</year>) <volume>1</volume>:<fpage>307</fpage>&#x2013;<lpage>10</lpage>.</citation>
</ref>
<ref id="B28">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmidt</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Witte</surname>
<given-names>OW</given-names>
</name>
<name>
<surname>Schleu&#xdf;ner</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Hoyer</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>Developing fetal motor-cardiovascular coordination analyzed from multi-channel magnetocardiography</article-title>. <source>Physiol Meas</source> (<year>2014</year>) <volume>35</volume>:<fpage>1943</fpage>&#x2013;<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1088/0967-3334/35/10/1943</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fenton</surname>
<given-names>TR</given-names>
</name>
</person-group>. <article-title>A new growth chart for preterm babies: babson and Benda&#x27;s chart updated with recent data and a new format</article-title>. <source>BMC Pediatr</source> (<year>2003</year>) <volume>3</volume>:<fpage>13</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2431-3-13</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haghighi</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>DK</given-names>
</name>
<name>
<surname>Oro</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Drake</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Kracke</surname>
<given-names>GR</given-names>
</name>
</person-group>. <article-title>Depressive effect of isoflurane anesthesia on motor evoked potentials</article-title>. <source>Neurosurgery</source> (<year>1990</year>) <volume>26</volume>:<fpage>993</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1227/00006123-199006000-00012</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weiskopf</surname>
<given-names>RB</given-names>
</name>
</person-group>. <article-title>Cardiovascular effects of desflurane in experimental-animals and volunteers</article-title>. <source>Anaesthesia</source> (<year>1995</year>) <volume>50</volume>:<fpage>14</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2044.1995.tb06184.x</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32.</label>
<citation citation-type="thesis">
<person-group person-group-type="author">
<name>
<surname>Winkens</surname>
<given-names>T</given-names>
</name>
</person-group>. <source>In-ovo Bildgebung an Strau&#xdf;eneiern &#x2013; Evaluierung einer Alternative zum klassischen Tierversuch</source>. <comment>Habilitation</comment>. <publisher-loc>Jena</publisher-loc>: <publisher-name>Friedrich-Schiller Universit&#xe4;t Jena</publisher-name> (<year>2022</year>).</citation>
</ref>
<ref id="B33">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosa</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Beier</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Oleskovicz</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Mezzalira</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Miquelutti</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Mezzalira</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group> <article-title>Effects of exposure to halothane, isoflurane, and sevoflurane on embryo viability and gestation in female mice</article-title>. <source>Semina: Ci&#xea;ncias Agr&#xe1;rias</source> (<year>2015</year>) <volume>36</volume>:<fpage>871</fpage>&#x2013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.5433/1679-0359.2015v36n2p871</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>Neonatal repeated exposure to isoflurane not sevoflurane in mice reversibly impaired spatial cognition at juvenile-age</article-title>. <source>Neurochem Res</source> (<year>2017</year>) <volume>42</volume>:<fpage>595</fpage>&#x2013;<lpage>605</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-016-2114-7</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brand</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Cloete</surname>
<given-names>SWP</given-names>
</name>
<name>
<surname>Malecki</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>CR</given-names>
</name>
</person-group>. <article-title>Ostrich (<italic>Struthio camelus</italic>) embryonic development from 7 to 42 days of incubation</article-title>. <source>Br Poult Sci</source> (<year>2017</year>) <volume>58</volume>:<fpage>139</fpage>&#x2013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1080/00071668.2016.1259529</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>